Pharmacosmos Hosts the 8th Uniferon Global Anaemia Summit

October 9, 2015

The 8thUniferon Global Anaemia Summit was held in Berlin, Germany from September 9-11, 2015.

A global delegation of leading swine producers, veterinarians and industry consultants representing more than 20 countries participated in this year's summit.

The purpose of this year's summit was to create awareness about the iron status in the herd as an indicator for performance, where a herds iron status may be determined by the hemoglobin level.

The international Iron Expert Board (IEB) presented their latest findings and an introduction to The F.A.C.T Calculator, a tool for optimizing a herds production potential, was given.

Lectures from guest speakers covered topics such as learnings from on-site anaemia investigations and Porcine Epidemic Diarrhea.

The outcome of each Summit is that the swine industry learns more about accurate pen-side anaemia detection and treatment protocols that help improve the producer's return on investment.

We would like to thank all the participants for their valuable contribution making the 8th Uniferon Global Anaemia Summit a huge success.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.